文献速递糖尿病

血管评估与新型生物标志物预测2型糖尿病心血管事件:SUMMIT VIP研究

Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study.
PubMed 文献 · Diabetes Care · 2018-07-30

该研究纳入936例2型糖尿病受试者,基线评估血管影像、功能及循环生物标志物,随访3年监测心血管事件。已存在心血管疾病者事件率高于无心血管疾病者(5.53 vs. 2.15/100生命年,P<0.0001)。已存在心血管疾病者的事件与炎症和内皮生物标志物相关,无心血管疾病者的事件与基线颈动脉斑块面积相关。

要点

  • 已存在心血管疾病的2型糖尿病患者中,炎症和内皮应激标志物反映心血管风险。
  • 无心血管疾病的2型糖尿病患者中,心血管事件风险主要与基线动脉粥样硬化严重程度相关。
  • 传统危险因素、动脉硬度和内皮反应性测量与心血管事件无关。

核心结论

  • 炎症和内皮应激标志物反映已存在心血管疾病的2型糖尿病受试者的心血管风险,而无心血管疾病者的心血管事件风险主要与动脉粥样硬化严重程度相关。

研究设计与样本

  • 研究队列由在四个欧洲中心招募的936例2型糖尿病受试者组成,基线分析颈动脉内膜中层厚度和斑块面积、踝臂血压指数、动脉硬度、内皮功能和循环生物标志物,并在3年随访期间监测心血管事件。

主要发现

  • 2型糖尿病受试者中心血管事件率在基线已存在心血管疾病者(n=440)高于无心血管疾病者(n=496)(5.53 vs. 2.15/100生命年,P<0.0001)。
  • 已存在心血管疾病的2型糖尿病受试者中新发心血管事件与基线较高的炎症生物标志物(白细胞介素6、趋化因子配体3、正五聚蛋白3和hs-CRP)及内皮促分裂原(肝细胞生长因子和血管内皮生长因子A)水平相关。
  • 无心血管疾病的2型糖尿病受试者中心血管事件与更严重的基线动脉粥样硬化相关(中位颈动脉斑块面积30.4 mm2 [16.1-92.2] vs. 19.5 mm2 [9.5-40.5],P=0.01)。
  • 传统危险因素以及动脉硬度和内皮反应性测量与心血管事件无关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cardiovascular disease (CVD) risk prediction represents an increasing clinical challenge in the treatment of diabetes. We used a panel of vascular imaging, functional assessments, and biomarkers reflecting different disease mechanisms to identify clinically useful markers of risk for cardiovascular (CV) events in subjects with type 2 diabetes (T2D) with or without manifest CVD. RESEARCH DESIGN AND METHODS: The study cohort consisted of 936 subjects with T2D recruited at four European centers. Carotid intima-media thickness and plaque area, ankle-brachial pressure index, arterial stiffness, endothelial function, and circulating biomarkers were analyzed at baseline, and CV events were monitored during a 3-year follow-up period. RESULTS: The CV event rate in subjects with T2D was higher in those with (n = 440) than in those without (n = 496) manifest CVD at baseline (5.53 vs. 2.15/100 life-years, P < 0.0001). New CV events in subjects with T2D with manifest CVD were associated with higher baseline levels of inflammatory biomarkers (interleukin 6, chemokine ligand 3, pentraxin 3, and hs-CRP) and endothelial mitogens (hepatocyte growth factor and vascular endothelial growth factor A), whereas CV events in subjects with T2D without manifest CVD were associated with more severe baseline atherosclerosis (median carotid plaque area 30.4 mm2 [16.1-92.2] vs. 19.5 mm2 [9.5-40.5], P = 0.01). Conventional risk factors, as well as measurements of arterial stiffness and endothelial reactivity, were not associated with CV events. CONCLUSIONS: Our observations demonstrate that markers of inflammation and endothelial stress reflect CV risk in subjects with T2D with manifest CVD, whereas the risk for CV events in subjects with T2D without manifest CVD is primarily related to the severity of atherosclerosis.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Shore AC, Colhoun HM, Natali A, et al. Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study. Diabetes Care. 2018. PMID: 30061319. doi:10.2337/dc18-0185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。